1st half day 2nd half day dash 1st half month 2nd half month dash 1st digit year 2nd digit year 3rd digit year last digit year
Ghrelin, The Weight Gain Protein

Written by Stuart Stevens | Tuesday, 01 August 2006

A new bit of research to find its way to the Ukmedix newsroom last month is now being reported all over the web and in newspapers. In the study that was also published in the National Academy of Sciences Journal saw that if rats were given a series of injections they stayed thin even when they ate alot more than they should and what would normally make them overweight.

The research is interesting because it may become commercially viable for humans to use the same treatment and the weight loss industry is worth billions each year around the world. In the study 17 rats were injected with a compound that was designed to trick their bodies into making a protein which is connected to weight gain inoperable and ineffective so that these rats gained less weight than the ones that were not injected. The researchers say that humans have the same protein so that the treatment is likely to work for them too and they are hoping that a practical and commercially workable solution can be found for the compound.

All in all 3 groups of rats were given different injections to stop the protein known as ghrelin. The researchers said that the injections mean that the rats gain less weight because their bodies become ineffective at metabolizing the food given to them. Ghrelin the new protein was only located 7 years ago and the production of it is considered to be method by which the human body reacts to differing food intake levels.

The obesity problem in America is massive having doubled from around 1980 and about a third of all US citizens are considered obese now with a BMI of 30 or more and about 2/3rds are considered to be overweight with a BMI of more than 25. Other drugs weight loss drugs on the market in America are Reductil and Xenical and they sell very well. The weight loss drug Acomplia is still being looked at by the FDA in the United States but is likely to be approved soon and GSK is planning on releasing a low dose version of Roche's Xenical weight loss treatment and call it Alli.

Ukmedix prides itself in that it always is up to date with the latest weight loss treatments and methods but always recommends that nothing beats good diet and exercise.

© 2008 This content has been exclusively written by UKMedix